← Back to headlines
AbbVie Seeks EMA Approval for Skyrizi in Crohn’s Disease Treatment
Pharmaceutical company AbbVie has formally submitted an application to the European Medicines Agency for regulatory approval of its biologic drug Skyrizi to treat Crohn’s disease.
27 Aug, 06:33 — 27 Aug, 06:33
Sources
Showing 1 of 1 sources
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
43m ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
2h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
3h ago
Study Reveals Hidden Arterial Calcification in Young Adults
4h ago